Smith & Nephew plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SNNUF research report →
Companywww.smith-nephew.com
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems.
- CEO
- Deepak S. Nath
- IPO
- 2009
- Employees
- 17,349
- HQ
- Watford, GB
Price Chart
Valuation
- Market Cap
- $12.71B
- P/E
- 20.89
- P/S
- 2.08
- P/B
- 2.52
- EV/EBITDA
- 9.87
- Div Yield
- 2.54%
Profitability
- Gross Margin
- 68.01%
- Op Margin
- 16.27%
- Net Margin
- 10.14%
- ROE
- 11.79%
- ROIC
- 9.11%
Growth & Income
- Revenue
- $6.30B · 8.45%
- Net Income
- $638.90M · 55.07%
- EPS
- $0.74 · 57.45%
- Op Income
- $1.03B
- FCF YoY
- 43.72%
Performance & Tape
- 52W High
- $18.50
- 52W Low
- $14.15
- 50D MA
- $15.78
- 200D MA
- $16.63
- Beta
- 0.67
- Avg Volume
- 674
Get TickerSpark's AI analysis on SNNUF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SNNUF Coverage
We haven't published any research on SNNUF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SNNUF Report →